The stock of Exelixis Inc. (NASDAQ:EXEL) increased by $0.07 on Tuesday to at $22.25, up 0.32 percent. The last five days have seen an average of 1,834,003 shares of common stock traded. 26 times new highs were reached in the current year, with a gain of $6.17. The average number of shares traded over the last 20 days was 2,435,916, while the average volume over the last 50 days totaled 2,304,496.
EXEL stock appreciated 12.89% since last month. On 07/31/23, the company’s shares reached a one-month low of $19.50. The stock touched a high of $22.30 on 08/29/23, after rallying from a low of $14.87 in 52 weeks. The price of EXEL stock has risen by 38.72% or $6.17 this year, reaching a new high 26 times. Still, the stock price is down -0.21% from the 52-week high.
Insider Transactions
EXEL stock investors should be aware that Exelixis Inc. (EXEL) stock had its last reported insider trading activity 25 days ago on Aug 04. On Aug 04, EVP and CFO Senner Christopher J. sold 60,000 shares at $20.68 each. This transaction resulted in the insider making $1,240,800. On Aug 03, Senner Christopher J. sold 60,000 shares at a price of US$20.51. After the transaction, the insider now owns 571,631 shares. EVP, Commercial Haley Patrick J. had earlier sold 30,553 shares on Aug 03 for $20.67 a share. The transaction was completed for $631,531.
Valuation Metrics
Exelixis Inc. (EXEL) has a trailing price-to-earnings (P/E) ratio of 44.23. Beta for the stock is 0.65. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 4.09, the price-to-book (PB) ratio of 2.85, and the price-to-cash flow ratio of 19.38.
Financial Health
For the three months ended June 29, Exelixis Inc.’s quick ratio was 4.60, while its current ratio was 4.70, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 96.30% percent. Exelixis Inc.’s EBITDA margin for the year ended June 29 was 14.94%, whereas its operating margin stood at 8.20% for the same period. Based on annual data, it had gross profit of $1.55 billion and revenue of $1.61 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. EXEL’s return on assets (ROA) during the last 12 months has been 5.30%. There was a 6.00% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 6.50%.
Earnings Surprise
According to Exelixis Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $469.85 million, while revenues rose by 10.73% to $408.79 million. It was predicted that Exelixis Inc.’s quarterly earnings would be $0.25, but it ended up being $0.16, beating the consensus by 56.20%. EBITDA was $83.89 million for the quarter. At the end of Exelixis Inc.’s most recent quarter ended June 29, its liabilities totaled 614.53 million, while its total debt was $194.69 million. Equity owned by shareholders amounts to $318.38 million.
Technical Picture
Here’s a quick look at Exelixis Inc.’s (EXEL) price momentum from a technical perspective. As of 28 August, the RSI 9-day stood at 78.77%, suggesting the stock is Overbought, with a 12.46% historical volatility rate.
The stochastic %K and %D were 91.19% and 90.37% respectively, while the average true range (ATR) was 0.36. Based on the 14-day stochastic reading of 87.10%, the RSI (14) reading is 74.08%. On the 9-day MACD Oscillator, the stock is at 0.48, and the 14-day reading is at 0.56.
Analyst Ratings
In a note to investors, Oppenheimer maintained its an Outperform rating on Exelixis Inc. (NASDAQ: EXEL). However, the firm raised their price target to $29, indicating a possible increase of 11.0% in the stock price. Analysts have assigned Exelixis Inc. (EXEL) an Overweight rating. EXEL is a stock that is recommended for selling by 1 brokerage firm, while 4 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 12 others recommend it as a buy.
What is EXEL’s price target for the next 12 months?
The current consensus forecast for the stock is between $18.00 and $32.00, with a median target price of $25.50. In analyzing these forecasts, the average price target given by analysts for Exelixis Inc. (EXEL) is $25.00.
